- ICH GCP
- 미국 임상 시험 레지스트리
- Search trials
임상 시험 검색 : Mesenchymal-epithelial transition factor (MET) inhibitor
총 125047 건
-
Chungbuk National University HospitalMerck KGaA, Darmstadt, Germany모병
-
Symphogen A/S완전한NSCLC | 비소세포폐암 | 종양학 | MET 유전자 돌연변이 | MET 유전자 증폭미국, 대한민국, 덴마크, 홍콩, 대만, 스페인
-
Fujian Cosunter Pharmaceutical Co. Ltd알려지지 않은고형종양 | C-Met Mutation-Related Tumors중국
-
Foundation University Islamabad모병
-
University of OsloThe Research Council of Norway; University of Oxford완전한
-
Elcelyx Therapeutics, Inc.완전한
-
University of OsloThe Research Council of Norway; University of Oxford완전한
-
University of Applied Sciences Upper AustriaKrankenhaus der Barmherzigen Schwestern Ried알려지지 않은
-
Dartmouth-Hitchcock Medical CenterNational Institute on Drug Abuse (NIDA)완전한
-
National University Hospital, Singapore아직 모집하지 않음
-
SCRI Development Innovations, LLCNovartis완전한
-
Deciphera Pharmaceuticals LLC종료됨
-
Brown UniversityNational Institute on Drug Abuse (NIDA)모집하지 않고 적극적으로
-
Haihe Biopharma Co., Ltd.모병
-
Louis Turcanu Emergency Hospital for ChildrenUniversity of Medicine and Pharmacy "Victor Babes" Timisoara완전한비만, 신진대사 양성
-
Alexandru Florin RogobeteUniversity of Medicine and Pharmacy "Victor Babes" Timisoara완전한
-
National Jewish HealthNational Heart, Lung, and Blood Institute (NHLBI); The Miriam Hospital; National Center for...완전한폐쇄성 수면 무호흡증 | 지속적인 양압미국
-
University of ConnecticutNational Institute on Alcohol Abuse and Alcoholism (NIAAA)완전한
-
Abion Inc모병
-
Guangdong Provincial People's HospitalShanghai Junshi Bioscience Co., Ltd.모병비소세포폐암 | BRAF V600 돌연변이 | MET 증폭 | MET Exon 14 건너뛰기 돌연변이 | RET 드라이버 돌연변이 | Erb-B2 수용체 티로신 키나제 엑손 20 돌연변이중국
-
New York State Psychiatric InstituteNational Institute on Drug Abuse (NIDA)완전한
-
Boston Children's Hospital초대로 등록
-
The Second Hospital of Nanjing Medical University알려지지 않은
-
Elcelyx Therapeutics, Inc.완전한
-
Pfizer완전한전신 역형성 대세포 림프종 | 비소세포폐암 ALK 양성 | 비소세포폐암 c-Met 의존성 | 비소세포폐암 ROS 마커 양성 | 백혈병을 제외한 진행성 악성종양미국, 대한민국, 호주, 일본